Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 223-229

  Noma, Hidetaka ^a   Funatsu, Hideharu ^a   Mimura, Tatsuya ^b   Eguchi, Shuichiro ^c   Shimada, Katsunori ^d  

^a Tokyo Women s Medical University   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Eguchi Eye Hospital   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Branch retinal vein occlusion; Macular edema; Pigment epithelium derived factor; Soluble intercellular adhesion molecule 1; Vascular endothelial growth factor; Vitrectomy

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POSTOPERATIVE PAIN; PROGNOSIS; RETINA FOVEA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 79952823860     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S16552     Document Type: Article

References (36)

1. Michels RG, Gass JD. The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol. 1974;78(2):OP166-OP177.
2. Gutman FA, Zegarra H. The natural course of temporal retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol. 1974; 78(2):OP178-OP192.
3. Noma H, Funatsu H, Mimura T, Harino S, Eguchi S, Hori S. Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Graefes Arch Clin Exp Ophthalmol. 2010;248(11):1559-1565.
4. Noma H, Funatsu H, Mimura T, Shimada K. Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study. J Inflamm (Lond). 2010;7(8):44.
5. Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K. Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series. BMC Ophthalmol. 2010; 10(4):11.
6. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98(3):271-282.
7. Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol. 2000;129(4):487-494.
8. Saika S, Tanaka T, Miyamoto T, Ohnishi Y. Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol. 2001;239(10):729-732.
9. Battaglia Parodi M, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 1999;237(12):1024-1027.
10. Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140(2):256-261.
11. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2006;244(3):309-315.
12. Noma H, Funatsu H, Yamasaki M, et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond). 2008;22(1):424-428.
13. Park SP, Ahn JK, Mun GH. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion. Retina. 2010;30(2):281-286.
14. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17(2):151-183.
15. Hogan MJ, Alvarado JA, Weddell JE. Histology of the Human Eye: An Atlas and Textbook. Philadelphia, PA: Saunders; 1971:492.
16. Fine BS, Brucker AJ. Macular edema and cystoid macular edema. Am J Ophthalmol. 1981;92(4):466-481.
17. Tso MO. Pathology of cystoid macular edema. Ophthalmology. 1982;89(8):902-915.
18. Yanoff M, Fine BS, Brucker AJ, Eagle RC Jr. Pathology of human cystoid macular edema. Surv Ophthalmol. 1984;28 Suppl:505-511.
19. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyper permeability, and angiogenesis. Am J Pathol. 1995;146(5):1029-1039.
20. Behzadian MA, Wang XL, Al-Shabrawey M, Caldwell RB. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia. 1998;24(2):216-225.
21. Vinores SA, Derevjanik NL, Ozaki H, Okamoto N, Campochiaro PA. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol. 1999;97(3-4):217-228.
22. Gardner TW, Antonetti DA, Barber AJ, Lieth E, Tarbell JA; Penn State Retina Research Group. The molecular structure and function of the inner blood-retinal barrier. Doc Ophthalmol. 1999;97(3-4):229-237.
23. Lu M, Perez VL, Ma N, et al. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999; 40(8):1808-1812.
24. Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A. 1999;96(19):10836-10841.
25. Ogata N, Ando A, Uyama M, Matsumura M. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol. 2001;239(2):87-95.
26. Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Imaizumi T. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis. Microvasc Res. 2006;72(1-2):86-90.
27. Liu H, Ren JG, Cooper WL, Hawkins CE, Cowan MR, Tong PY. Identification of the antivasopermeability effect of pigment epitheliumderived factor and its active site. Proc Natl Acad Sci U S A. 2004; 101(17):6605-6610.
28. Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX. Pigment epithelium- derived factor (PEDF) is an endogenous anti-inflammatory factor. FASEB J. 2006;20(2):323-325.
29. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996;103(11): 1820-1828.
30. Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol. 2007;143(4):601-606.
31. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27(4): 419-425.
32. Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther. 2008;16(4):791-799.
33. Noma H, Funatsu H, Mimura T, Hori S. Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol. 2008;18(6):1017-1019.
34. Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 1990;31(2):284-289.
35. Suzuma K, Kita M, Yamana T, et al. Quantitative assessment of macular edema with retinal vein occlusion. Am J Ophthalmol. 1998;126(3):409-416.
36. Imasawa M, Iijima H, Morimoto T. Perimetric sensitivity and retinal thickness in eyes with macular edema resulting from branch retinal vein occlusion. Am J Ophthalmol. 2001;131(1):55-60.